tm logo
KOMIPHARM
Dead/Cancelled
CANCELLED – SECTION 71

on 09 Jun 2023

Last Applicant/ Owned by

17, Gyeongje-ro, Siheung-si Gyeonggi-do

KR

Serial Number

79172263 filed on 08th May 2015

Registration Number

5084132 registered on 22nd Nov 2016

in the Principal Register

Correspondent Address

Yoon S. Ham

Yoon S. Ham

Suite 1400

2318 Mill Road

Alexandria VA 22314

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

KOMIPHARM

Disinfectants for hygiene purposes; Veterinary preparations, namely, pain relief medication, medication for treatment of intestinal bacteria, antioxidants; Deodorizing preparations for household, commercial or industrial use for pet litter boxes, carpets; Household deodorant; Insecticides; Germicides; Insect repellents; Medicines for veterinary purposes, namely, medicines for treatment of porcine Read More

Classification Information


Class [005]
Pharmaceutical Products


Disinfectants for hygiene purposes; Veterinary preparations, namely, pain relief medication, medication for treatment of intestinal bacteria, antioxidants; Deodorizing preparations for household, commercial or industrial use for pet litter boxes, carpets; Household deodorant; Insecticides; Germicides; Insect repellents; Medicines for veterinary purposes, namely, medicines for treatment of porcine circoviral disease, porcine epidemic diarrhea, transmissible gastroenteritis, rotavirus infection pasteurellosis, pleuropneumoniae, classical swine fever, swine erysipelas, swine mycoplasmoses, akabane disease, pasteurellosis, colibacillosis, bovine ephemeral fever, newcastle disease, infectious bronchitis, low pathogenicity avian influenza, infectious bursal disease, salmonellosis, rabies, canine distemper, infectious canine hepatitis, parvovirus infection, coronavirus infection, leptospirosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Antibiotic preparations; Chemotherapeutics; Tumor suppressing agents; Pharmaceutical preparations acting on the central nervous system; Cardiovascular pharmaceutical preparations; Pharmaceutical agents affecting metabolism; Chemical preparations for pharmaceutical purposes, namely, for the treatment of pain and inflammation associated with cancer, the treatment of cancer, the treatment of leukemia and lymphoma, the treatment of metastatic neoplastic diseases, the treatment of brain tumors, cancer stem cell-targeted and drug resistant cancer therapy, the treatment of urogenital cancer and its metastasis; Biological preparations for the treatment of porcine circoviral disease, porcine epidemic diarrhea, transmissible gastroenteritis, rotavirus infection pasteurellosis, pleuropneumoniae, classical swine fever, swine erysipelas, swine mycoplasmoses, akabane disease, pasteurellosis, colibacillosis, bovine ephemeral fever, newcastle disease, infectious bronchitis, low pathogenicity avian influenza, infectious bursal disease, salmonellosis, rabies, canine distemper, infectious canine hepatitis, parvovirus infection, coronavirus infection, leptospirosis

Mark Details


Serial Number

No 79172263

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 123027-0138T

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
11th Mar 2024TOTAL INVALIDATION PROCESSED BY THE IB
20th Feb 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
19th Feb 2024INVALIDATION PROCESSED
09th Feb 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
09th Jun 2023CANCELLED SECTION 71
22nd Nov 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
25th Mar 2017FINAL DECISION TRANSACTION PROCESSED BY IB
07th Mar 2017FINAL DISPOSITION PROCESSED
07th Mar 2017FINAL DISPOSITION NOTICE SENT TO IB
22nd Feb 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB